Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioenergetic Alterations After Exenatide Administration
NCT00623545Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2008
- Primary completion
- Apr 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in obesity, sponsored by University of Wisconsin–Madison. Started Jan 2008; status: completed.
02
Drugs
exenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00623545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623545.